(Q28274372)
Statements
Metergoline blocks the behavioral and neuroendocrine effects of orally administered m-chlorophenylpiperazine in patients with obsessive-compulsive disorder (English)
0 references
1 March 1991
0 references
29
0 references
418-26
0 references
5
0 references